Lantern Pharma is trading 5.79% up at $1.28, primarily in line with broader risk-on market sentiment.
- The move follows a September 24 close of $1.21, after a 12.95% decline.
- Major indexes are up more than 0.5%.
- No verified company-specific announcement was found for September 25, 2026; the latest identified company communication concerned the September 23 Open-Medicine AI presentation and related platform updates.